Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Aphea.Bio from Gent, company number BE0666961607, closed financial year 2025 with a result of € -14.1 million after tax. For that financial year Aphea.Bio recorded revenue of € 14,118 and equity of € 11.4 million. Compared with financial year 2024, the result moved from € -14.5 million to € -14.1 million. The company made a loss. The buffer shrank hard: equity is 55 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 11.4 million
▼ 55% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -14.1 million
▲ 3 % less loss than in 2024
Profit after tax over the fiscal year.
€ 580,919
▼ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -40.5 million.
People and assets in 2025
56.9
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 6.1 million
▲ 11% vs 2024
€ 107,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 57,973
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.8 million
▲ 26% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 63 days on average.
€ 657,545
▼ 48% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 23,000 | € 14,118 | ▼ 39% |
| Gross margin | € -4,112,320 | € 2,028,133 | - | - | |
| Profit after taxes | € -7,792,623 | € -11,878,253 | € -14,542,239 | € -14,088,156 | ▲ € 454,083 |
| Equity | € 5,288,645 | € 16,535,392 | € 25,534,820 | € 11,446,664 | ▼ 55% |
| Total debts | € 2,038,572 | € 3,367,037 | € 4,821,712 | € 4,796,544 | ▼ 1% |
| Cash | € 3,927,742 | € 1,058,571 | € 949,303 | € 580,919 | ▼ 39% |
| Retained profit | € -12,776,149 | € -11,878,253 | € -26,420,492 | € -40,508,648 | ▼ € 14.1 million |
| Balance sheet total | € 7,336,001 | € 19,902,429 | € 30,356,532 | € 16,243,207 | ▼ 46% |
| Employees (FTE) | 39.3 | 46.7 | 56.6 | 56.9 | ▲ 0.3 |
Key figures of Aphea.Bio, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Aphea.Bio?
What happened at Aphea.Bio in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Innovation Industries Management III B.V. BV stepped down as director. NBB
- KORYS MANAGEMENT NV stepped down as director. NBB
- Isabel Vercauteren stepped down as director. NBB
- FEDERALE PARTICIPATIE – EN INVESTERINGSMAATSCHAPPIJ NV - SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT SA NV stepped down as director. NBB
- Hartmut van Lengerich stepped down as director. NBB
- Agri Investment Fund BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 14.1 million. filed late Source: NBB ↗
- Hendrik Van Asbroeck stepped down as director. NBB
In short
From € 7.8 million loss in 2022 to € 14.1 million loss in 2025.
On average € 43,400 of value added per employee in 2023.
Pays suppliers within 63 days on average.
Management
The stake of Agri Investment Fund, QBIC II FUND ARKIV, BIOTECH FONDS VLAANDEREN, VIVES II - Louvain Technology Fund comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Aphea.BioThe shares are held by Agri Investment Fund (10.9%), QBIC II FUND ARKIV (4.9%), BIOTECH FONDS VLAANDEREN (4.4%) and VIVES II - Louvain Technology Fund (3.5%).
Directors
According to the 2025 annual accounts
since 2025 · until 2026
Laetitia De Panafieu
Director
since 2023 · until 2025
Innovation Industries Management III B.V. BV
Director · represented by Caaj Greebe
since 2023 · until 2032
Stéphane Roussel
Director
since 2025 · until 2026
Director · represented by David Devigne
Also active at: Colruyt Group, GINSTBRONNEN, reMYND, D-DRINKS GROUP, FLUVES, SOFINDEV IV, URBANTZ, Pantarein Water +19 more
since 2023 · until 2032
since 2023 · until 2032
Director · represented by Peter De Decker
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale, COMETSAMBRE, ASCO INDUSTRIES, ZEPHYR - FIN, Sabena Aerospace Engineering, reMYND +58 more
since 2026 · until 2032
Isabelle Laurencin
Director
since 2025 · until 2025
Hartmut van Lengerich
Director
since 2025 · until 2032
since 2021 · until 2032
Hadyn Parry
Director
since 2023 · until 2026
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 21
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
aphea.bio
Registered
2016-08-17
Registrar
Key-Systems, LLC
Expires
2026-08-17
Website info
Features
Security
Network
Details
- Company number
- 0666.961.607
- VAT number
- BE 0666.961.607
- Registered office
- Technologiepark-Zwijnaarde 21, 9052 Gent
- Names & denominations
- Aphea.Bio
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 2016
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- aphea.bio [email protected]
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw